The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the reason for doing that again comes back to the mouse data in part because we as I mentioned we've published that a short-term treatment in mice is enough to give you large benefits on lifespan and at least some measures of health and also because again as we're thinking about ultimately bringing this to people it's easier to envision transient performance treatment than it is a continuous for the rest of your life sort of treatment
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.